Palmitoylethanolamide
Food supplement declared in France, declaration No 2020-10-1179, decision dated 28 October 2020
Palmitoylethanolamide (DYNVEO) is a food supplement declared in France. Status: déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité). None of the rules we check flags an issue with its declared composition; vitamin and mineral doses are not published by Compl'Alim and are therefore not checked.
- Brand
- DYNVEO
- Food business operator placing the product on the market
- DYNVEO (NUTRAVEO)
- Status
- Déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité)
- Form
- Gélule
- Daily dose
- 1200 mg (3 gélules)
- Directions for use
- Prendre une gélule par jour avec un verre d'eau
- Not recommended for (according to the manufacturer)
- Adolescents (moins de 18 ans), Femmes allaitantes, Calculs rénaux, Enfants (moins de 12 ans), Enfants en bas âge (1 à 3 ans), Femmes enceintes, Insuffisance rénale, Maladie rénale, Nourrissons (moins de 1 an)
Declaration 170901, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.
Regulatory points
None of the rules we check applies to the declared ingredients.
Declared composition
Other active ingredients
| Name | Per day |
|---|---|
| Palmitoyléthanolamide | not declared |
List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).
List recorded in 2020. Photograph the packaging to check whether it has changed. Photograph the packaging
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Brand : DYNVEO